A new market study, titled “Global Anti-Obesity Prescription Market Research Report 2019” has been featured on WiseGuyReports.
Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory failure, renal failure and asthma. According to a World Health Organization (WHO) report published in 2014, around 3.4 million adults in the world die each year due to obesity related issues. Increasing prevalence of obesity among children and adults is posing a threat and developing nations. Effective intervention strategies such as increased physical activity, behavioral and dietary changes are commonly used to control and prevent obesity. Obesity has a major impact on population longevity and health related expense.
There is increased use of anti-obesity prescription due to increasing obesity endemic. Sedentary lifestyle and junk food habits, increasing healthcare expenditure and rise in aging population are some of the key factors driving the growth for global anti-obesity prescription market. In addition, increasing healthcare awareness is also fuelling the growth of the global anti-obesity prescription market. However, side effects of anti-obesity drugs, high drug development cost and strict regulatory framework are some of the major factors restraining the growth for the global anti-obesity prescription market.
The global Anti-Obesity Prescription market is valued to grow with healthy CAGR rate during 2019-2025.
This report focuses on Anti-Obesity Prescription volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Obesity Prescription market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Segment by Regions
Segment by Type
Bupropion and Naltrexone
Phentermine and Topiramate
Segment by Application
Request Free Sample Report at https://www.wiseguyreports.com/sample-request/3820412-global-anti-obesity-prescription-market-research-report-2019
Table of Contents
1 Anti-Obesity Prescription Market Overview
2 Global Anti-Obesity Prescription Market Competition by Manufacturers
3 Global Anti-Obesity Prescription Production Market Share by Regions
4 Global Anti-Obesity Prescription Consumption by Regions
5 Global Anti-Obesity Prescription Production, Revenue, Price Trend by Type
6 Global Anti-Obesity Prescription Market Analysis by Applications
7 Company Profiles and Key Figures in Anti-Obesity Prescription Business
8 Anti-Obesity Prescription Manufacturing Cost Analysis
9 Marketing Channel, Distributors and Customers
10 Market Dynamics
11 Global Anti-Obesity Prescription Market Forecast
12 Research Findings and Conclusion
13 Methodology and Data Source
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)